Hongying Xiao

The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery

Yun Xia, Yonghua Xie, Zhengsen Yu et al. · Cell · 2018 · 241 citations · Full text

Vaccination, Druggable Target, Vaccine Development +11

KRAS(G12D) can be targeted by potent inhibitors via formation of salt bridge

Zhongwei Mao, Hongying Xiao, Pan‐Pan Shen et al. · Cell Discovery · 2022 · 137 citations · Full text

A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation

Yunyun Yang, Liping Li, Linjie Yuan et al. · Immunity · 2019 · 130 citations · Full text

Molecular Immunology, Signal Transduction, Immune Cell Development +14

Aberrant human ClpP activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma

Pengyu Wang, Tao Zhang, Xinjing Wang et al. · Cell chemical biology · 2022 · 55 citations

Tumor Biology, Signal Transduction, Pancreatic Cancer +9

Combining Vγ9Vδ2 T Cells with a Lipophilic Bisphosphonate Efficiently Kills Activated Hepatic Stellate Cells

Xiaoying Zhou, Yanzheng Gu, Hongying Xiao et al. · Frontiers in Immunology · 2017 · 13 citations · Full text

Hepatic Stellate Cells, Immunology, Immune Regulation +19